Albemarle Corporation ALB

GlobeNewswire Inc. 12 nov

The global specialty zeolites market is projected to grow from US$1 million in 2025 to US$1.5 million by 2032, expanding at a CAGR of 5.8%. Growth is driven by stricter environmental regulations, advances in catalyst technologies, and rising demand for sustainable materials across water treatment, petrochemicals, automotive, construction, agriculture, and household care. Synthetic zeolites are expected to grow faster at 7.3% CAGR compared to natural zeolites at 4.9%, with China showing strong growth at 8.8% CAGR.

Zacks Investment Research 11 nov

The article examines the reliability of brokerage analyst recommendations versus Zacks Rank, a proprietary stock-rating tool. Using Albemarle (ALB) as an example, it demonstrates how brokerage firms show positive bias in their ratings due to vested interests, issuing five 'Strong Buy' recommendations for every 'Strong Sell.' While ALB has an average brokerage recommendation of 1.83 (Buy-equivalent), its Zacks Rank is #4 (Sell) due to a 4.4% decline in consensus earnings estimates over the past month. The article argues that Zacks Rank, based on earnings estimate revisions, is a more reliable predictor of near-term stock price movements than traditional analyst recommendations.

Zacks Investment Research 10 nov

Albemarle Corporation is a trending stock with strong recent performance. The specialty chemicals company has returned +0.6% over the past month and is expected to post significant earnings growth of +1472.2% for the current fiscal year. However, the company received a Zacks Rank #3 (Hold) rating, suggesting it may perform in line with the broader market in the near term. The stock is trading at a discount to peers with a B valuation grade.

Zacks Investment Research 10 nov

The article explains how to identify stocks poised to beat earnings expectations using the Zacks Earnings ESP (Expected Surprise Prediction) tool, which compares recent analyst revisions against consensus estimates. Two Basic Materials stocks highlighted are SQM with an +8.25% ESP ahead of November 17 earnings, and Albemarle with an +8.44% ESP before February 10, 2027 earnings. Both stocks have positive ESPs suggesting potential earnings beats.

Zacks Investment Research 6 nov

Albemarle Corporation beat Q3 earnings and revenue estimates, reporting adjusted EPS of $2.58 vs. consensus of $2.56, driven by improved Energy Storage pricing and Specialties performance. The company raised its 2026 Specialties EBITDA outlook to $350M-$375M, cut capex to $300M-$350M, and targets 240,000-260,000 tons of lithium sales in 2027. Management highlighted 48% year-to-date growth in global lithium consumption and strong long-term demand despite near-term pricing volatility.